Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 17 February 1984:
Vol. 223. no. 4637, pp. 703 - 707
DOI: 10.1126/science.6320367

Articles

Science, Vol 223, Issue 4637, 703-707
Copyright © 1984 by American Association for the Advancement of Science


articles

Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I

SZ Salahuddin, PD Markham, SG Lindner, J Gootenberg, M Popovic, H Hemmi, PS Sarin, and RC Gallo

Cell-free conditioned media from human T cells transformed by human T-cell leukemia-lymphoma virus (HTLV-I) were tested for the production of soluble biologically active factors, including several known lymphokines. The cell lines used were established from patients with T-cell leukemia-lymphoma and from human umbilical cord blood and bone marrow leukocytes transformed by HTLV-I in vitro. All of the cell lines liberated constitutively one or more of the 12 biological activities assayed. These included macrophage migration inhibitory factor (MIF), leukocyte migration inhibitory factor (LIF), leukocyte migration enhancing factor (MEF), macrophage activating factor (MAF), differentiation inducing factor (DIF), colony stimulating factor (CSF), eosinophil growth and maturation activity (eos. GMA), fibroblast activating factor (FAF), gamma-interferon and, in rare instances, T-cell growth factor (TCGF). Some cell lines produced interleukin 3 (IL-3), platelet-derived growth factor (PDGF), or B-cell growth factors (BCGF). Such cells should prove useful for the production of lymphokines and as sources of specific messenger RNA's for their genetic cloning.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Roscovitine Inhibits STAT5 Activity and Induces Apoptosis in the Human Leukemia Virus Type 1-Transformed Cell Line MT-2.
S. Mohapatra, B. Chu, S. Wei, J. Djeu, P. K. Epling-Burnette, T. Loughran, R. Jove, and W. J. Pledger (2003)
Cancer Res. 63, 8523-8530
   Abstract »    Full Text »    PDF »
Exaggerated Messenger RNA Expression of Inflammatory Cytokines in Human T-Cell Lymphotropic Virus Type I--Associated Myelopathy.
H. Watanabe, T. Nakamura, K. Nagasato, S. Shirabe, K. Ohishi, K. Ichinose, Y. Nishiura, S. Chiyoda, M. Tsujihata, and S. Nagataki (1995)
Arch Neurol 52, 276-280
   Abstract »    PDF »
Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection.
P. Hollsberg and D. A. Hafler (1993)
N. Engl. J. Med. 328, 1173-1182
   Full Text »
Expression of a zinc finger gene in HTLV-I- and HTLV-II-transformed cells.
J. Wright, K. Gunter, H Mitsuya, S. Irving, K Kelly, and U Siebenlist (1990)
Science 248, 588-591
   Abstract »    PDF »
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.
S Nakamura, S. Salahuddin, P Biberfeld, B Ensoli, P. Markham, F Wong-Staal, and R. Gallo (1988)
Science 242, 426-430
   Abstract »    PDF »
HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis.
D. Mann, P DeSantis, G Mark, A Pfeifer, M Newman, N Gibbs, M Popovic, M. Sarngadharan, R. Gallo, J Clark, et al. (1987)
Science 236, 1103-1106
   Abstract »    PDF »
Calcitriol Levels in Hypercalcemic Patients With Adult T-Cell Lymphoma.
R. C. Dodd, C. F. Winkler, M. E. Williams, P. A. Bunn, and T. K. Gray (1986)
Arch Intern Med 146, 1971-1972
   Abstract »    PDF »
Evidence for HTLV-I Associated With Mycosis Fungoides and B-Cell Chronic Lymphocytic Leukemia.
A. Peterman, Myles, S. Staal, Bradley, H. Striecher, J. Schupbach, and L. Resnick (1986)
Arch Dermatol 122, 568-571
   Abstract »    PDF »
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors.
J Laurence and L Mayer (1984)
Science 225, 66-69
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)